Medscape is available in 5 Language Editions – Choose your Edition here.


Aniridia in the Newborn Clinical Presentation

  • Author: Sophie Bakri, MD; Chief Editor: Hampton Roy, Sr, MD  more...
Updated: Dec 03, 2013


An infant may come to medical attention with nystagmus or photophobia. Patients may present with strabismus and amblyopia. The family may notice an abnormal pupil, or they may describe a fixed, dilated pupil.



Visual acuity is reduced, usually to around the 20/100 level. Pendular nystagmus, strabismus, and amblyopia may be present. Nystagmus occurs in 85-92% of patients. Ocular examination reveals absence of the irides or dilated unresponsive pupils. Other findings may include small anterior polar cataracts, pupillary membrane remnants, ectopia lentis (in 18-35%), corneal pannus, progressive keratopathy, and optic nerve or foveal hypoplasia.

Poor vision in infancy often is due to foveal or optic nerve hypoplasia and secondary nystagmus. Acquired vision loss may be due to cataract (present in 85% of cases), glaucoma (present in 70%), keratopathy, or amblyopia.

Some have considered aniridia a misnomer because a rudimentary stump of tissue usually can be found behind the limbal sclera by gonioscopy. The diagnosis can be very difficult to make in patients with a substantial amount of iris tissue. However, characteristic absence of the pupillary rim, iris sphincter muscle, and central iris tissue is noted.

  • Syndromes associated with aniridia
    • Miller syndrome (WAGR complex, 11p- syndrome)
      • Approximately 30% of patients with sporadic aniridia develop Wilms tumor, usually before age 5 years. The association between aniridia and Wilms tumor is referred to as Miller syndrome, after his 1964 report of 6 cases of aniridia among 440 cases of Wilms tumor. It was reported that 1.4% of patients with Wilms tumor have aniridia compared to 1 in 64,000 to 1 in 100,000 of the general population.
      • Affected children have other genitourinary abnormalities, craniofacial dysmorphism, hemihypertrophy, and severe mental retardation. They also may have poorly lobulated low-set ears, prominent noses, and long narrow facies. The acronym WAGR (Wilms tumor, aniridia, genitourinary anomalies, and mental retardation) describes some of the features of Miller syndrome.
      • Miller syndrome has been attributed to a deletion of band 11p13. Patients with sporadic aniridia should undergo a thorough physical examination and workup by a family practitioner or pediatrician.
    • Gillespie syndrome
      • Gillespie syndrome is the association of aniridia, cerebellar ataxia, and mental retardation. It is autosomal recessive, occurring in approximately 2% of patients with aniridia. These patients have anatomical defects in the cerebellum and other parts of the brain, and they are not predisposed to developing Wilms tumor.
      • A study of the PAX6 gene in Gillespie syndrome failed to find a mutation, suggesting that abnormalities in the PAX6 gene are not responsible for this syndrome.
    • Glaucoma
      • Glaucoma is one of the major causes of visual loss in patients with aniridia, with a reported incidence of 6-75%. This variation is explained by the referral patterns of the various institutions, the variable phenotypic expression of aniridia, and the definitions of glaucoma. Glaucoma in aniridia is rare in infants and newborns and typically is acquired in early adulthood. As a result of its delayed onset, the clinical findings of megalocornea, buphthalmos, and Haab striae typically are not found.
      • Progressive apposition of the rudimentary stump of iris to the trabecular meshwork is believed to occur during the first 2 decades of life. In patients without glaucoma, the structures of the anterior chamber angle appear normal by gonioscopy. In older patients with aniridic glaucoma, the severity of the glaucoma is related to the proportion of the filtration angle covered by the iris stump. The periphery of the hypoplastic stump of iris may insert anteriorly, and even where it is more open, the scleral spur and ciliary body band may be defined poorly. In the rare cases of infants with aniridic glaucoma, filtration-angle defects are present at birth. In these cases, the angle usually is covered by vascularized sheets extending from the iris, rather than being blocked by the iris stump.
    • Cataracts
      • Cataracts occur in 50-85% of patients with aniridia, usually acquired during the first 2 decades of life. At birth, small lens opacities may be noted, but these typically are not visually significant. Types of cataracts described include anterior polar, pyramidal, nuclear, lamellar, and cortical.
      • Visually significant cataracts in neonates require prompt surgical extraction to prevent amblyopia. However, in patients whose cataracts develop later, the factor most strongly limiting visual acuity is the presence of foveal hypoplasia, not the cataract. Areas of clear space may be present in the cataractous lens, which allows for relatively good vision. In these patients, surgery is best delayed, since the risks of glaucoma developing or progressing in aniridic eyes outweighs the small potential for visual improvement.
    • Ectopia lentis: Some investigators have reported lens subluxations in as many as 56% of eyes with aniridia, while others have reported none. This finding may be due to failure to detect mild cases. The zonules are believed to be histologically normal, but their molecular structure is not understood clearly.
    • Corneal defects
      • Progressive corneal opacification and pannus occur in most patients, developing as early as age 2 years. Initially, fine radial vessels invade the superficial layers of the peripheral cornea at the 6- and 12-o'clock positions and, then, involve the whole circumference. This process may progress to involve the entire cornea, requiring corneal transplantation.
      • Pathologically, the pannus seen in aniridic keratopathy is quite unusual; the corneal epithelium may harbor ectopic conjunctival goblet cells, and inflammatory cells are usually present. The pathogenesis is uncertain, but many theories have been proposed. It has been attributed to a total absence of the limbal girdles of Vogt and corneal epithelial limbal stem cells. PAX6 has been found in corneal and conjunctival epithelia, and it is believed that this gene may play a role in the activity of corneal stem cells.
      • Microcornea also has been found in most cases of aniridia.
    • Optic nerve and foveal hypoplasia
      • Posterior segment abnormalities include both macular and optic nerve hypoplasia. Approximately 75% of patients with aniridia have some degree of optic nerve hypoplasia. The macula and optic nerve are usually normal in patients with Gillespie syndrome. Mild cases may be difficult to detect because of nystagmus and corneal or lens opacities. Poor macular or retinal development may be responsible for the optic nerve hypoplasia. Because the retina is derived from neuroectoderm, as are the iris epithelium and musculature, foveal hypoplasia often is associated with aniridia.
      • Decreased vision and nystagmus in patients with aniridia result from faulty development of the macula, not the iris. There appears to be no correlation between the degree of iris hypoplasia and foveal hypoplasia. In some patients, foveal hypoplasia may be so subtle that fluorescein angiography may be necessary to demonstrate lack of the foveal avascular zone.
    • Strabismus: This is a common finding in patients with aniridia, and esotropia most frequently is found. A full cycloplegic refraction is warranted because amblyopia may occur from anisometropia or strabismus.
    • Nystagmus: This is commonly pendular secondary to poor vision from foveal hypoplasia. It may improve with visual maturation.
  • Other findings
    • Peripheral retinal lipoidal deposits have been reported in at least 3 patients.
    • Electroretinogram (ERG) amplitudes are low in patients with worse than 20/60 vision, while patients with better vision may have high a:b wave ratios.


Aniridia may be familial or sporadic. It is caused by a mutation in the PAX6 gene on chromosome 11.

Contributor Information and Disclosures

Sophie Bakri, MD Assistant Professor of Ophthalmology, Vitreoretinal Diseases and Surgery, Mayo Clinic of Rochester

Sophie Bakri, MD is a member of the following medical societies: American Academy of Ophthalmology

Disclosure: Nothing to disclose.


John W Simon, MD 

John W Simon, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

J James Rowsey, MD Former Director of Corneal Services, St Luke's Cataract and Laser Institute

J James Rowsey, MD is a member of the following medical societies: American Academy of Ophthalmology, American Association for the Advancement of Science, American Medical Association, Association for Research in Vision and Ophthalmology, Florida Medical Association, Sigma Xi, Southern Medical Association, Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy, Sr, MD Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Hampton Roy, Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

Additional Contributors

Gerhard W Cibis, MD Clinical Professor, Director of Pediatric Ophthalmology Service, Department of Ophthalmology, University of Kansas School of Medicine

Gerhard W Cibis, MD is a member of the following medical societies: American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, American Ophthalmological Society

Disclosure: Nothing to disclose.

  1. Edén U, Riise R, Tornqvist K. Corneal involvement in congenital aniridia. Cornea. 2010 Oct. 29(10):1096-102. [Medline].

  2. Brémond-Gignac D, Bitoun P, Reis LM, Copin H, Murray JC, Semina EV. Identification of dominant FOXE3 and PAX6 mutations in patients with congenital cataract and aniridia. Mol Vis. 2010 Aug 22. 16:1705-11. [Medline]. [Full Text].

  3. Nelson LB, Spaeth GL, Nowinski TS, et al. Aniridia. A review. Surv Ophthalmol. 1984 May-Jun. 28(6):621-42. [Medline].

  4. Brauner SC, Walton DS, Chen TC. Aniridia. Int Ophthalmol Clin. 2008 Spring. 48(2):79-85. [Medline].

  5. Callahan A. Aniridia with ectopia lentis and secondary glaucoma. Am J Ophthalmol. 1949. 32:28.

  6. Chen TC, Walton DS. Goniosurgery for prevention of aniridic glaucoma. Arch Ophthalmol. 1999 Sep. 117(9):1144-8. [Medline].

  7. Edén U, Iggman D, Riise R, Tornqvist K. Epidemiology of aniridia in Sweden and Norway. Acta Ophthalmol. 2008 May 19. [Medline].

  8. Grant WM, Walton DS. Progressive changes in the angle in congenital aniridia, with development of glaucoma. Am J Ophthalmol. 1974 Nov. 78(5):842-7. [Medline].

  9. Hamming N, Wilensky J. Persistent pupillary membrane associated with aniridia. Am J Ophthalmol. 1978 Jul. 86(1):118-20. [Medline].

  10. Hittner HM, Riccardi VM, Ferrell RE, et al. Variable expressivity in autosomal dominant aniridia by clinical, electrophysiologic, and angiographic criteria. Am J Ophthalmol. 1980 Apr. 89(4):531-9. [Medline].

  11. Jastaneiah S, Al-Rajhi AA. Association of aniridia and dry eyes. Ophthalmology. 2005 Sep. 112(9):1535-40. [Medline].

  12. Jesberg DO. Aniridia with retinal lipid deposits. Arch Ophthalmol. 1962 Sep. 68:331-6. [Medline].

  13. Koroma BM, Yang JM, Sundin OH. The Pax-6 homeobox gene is expressed throughout the corneal and conjunctival epithelia. Invest Ophthalmol Vis Sci. 1997 Jan. 38(1):108-20. [Medline].

  14. Kremer I, Rajpal RK, Rapuano CJ, et al. Results of penetrating keratoplasty in aniridia. Am J Ophthalmol. 1993 Mar 15. 115(3):317-20. [Medline].

  15. Layman PR, Anderson DR, Flynn JT. Frequent occurrence of hypoplastic optic disks in patients with aniridia. Am J Ophthalmol. 1974 Apr. 77(4):513-6. [Medline].

  16. Mackman G, Brightbill FS, Optiz JM. Corneal changes in aniridia. Am J Ophthalmol. 1979 Apr. 87(4):497-502. [Medline].

  17. Margo CE. Congenital aniridia: a histopathologic study of the anterior segment in children. J Pediatr Ophthalmol Strabismus. 1983 Sep-Oct. 20(5):192-8. [Medline].

  18. Menezo JL, Martinez-Costa R, Cisneros A, et al. Implantation of iris devices in congenital and traumatic aniridias: surgery solutions and complications. Eur J Ophthalmol. 2005 Jul-Aug. 15(4):451-7. [Medline].

  19. Nishida K, Kinoshita S, Ohashi Y, et al. Ocular surface abnormalities in aniridia. Am J Ophthalmol. 1995 Sep. 120(3):368-75. [Medline].

  20. Ramaesh K, Ramaesh T, Dutton GN, et al. Evolving concepts on the pathogenic mechanisms of aniridia related keratopathy. Int J Biochem Cell Biol. 2005 Mar. 37(3):547-57. [Medline].

  21. Warburg M, Mikkelsen M, Andersen SR, et al. Aniridia and interstitial deletion of the short arm of chromosome 11. Metab Pediatr Ophthalmol. 1980. 4(2):97-102. [Medline].

  22. Wiggins RE Jr, Tomey KF. The results of glaucoma surgery in aniridia. Arch Ophthalmol. 1992 Apr. 110(4):503-5. [Medline].

Aniridia. Note the almost complete absence of the iris.
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.